Industry body overhauls finances

The Thoracic Society of Australia and New Zealand (TSANZ) has recorded a stunning about-face in its financials, sailing back into the black and reversing consecutive losses in 2022 and 2023 totalling about $1 million, with a 269 per cent improvement in financial performance year-on-year.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here